AgingResearch.NewsJoin free

Jiangsu Nhwa Pharmaceutical

CompanyChinaFounded 1978

RORWikidata

Jiangsu Nhwa Pharmaceutical develops one asset, in phase 3 (fentanyl in safety of gastroscopy). Mostly small molecule acting on OPRM1; based in China, founded in 1978.

1
Asset
Furthest stage
Phase 3
2
Trials
6
Signals

Pipeline

1

  • fentanyl

    Potent mu-opioid receptor agonist providing analgesia and sedation.

    Phase 3, Small molecule, OPRM1, safety of gastroscopy

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials3
  • Signals20
  • Similar companies6

Papers

Intelligence